REP LIEU STATEMENT ON FDA APPROVAL OF GENE THERAPY FOR CERTAIN LYMPHOMAS

October 19, 2017
Press Release

FOR IMMEDIATE RELEASE

WASHINGTON - Today, Congressman Ted W. Lieu (D | Los Angeles County) issued the following statement after the Food and Drug Administration approved the use of gene therapy for certain types of non-Hodgkin lymphoma.

"This is fantastic news. Immunotherapy is a promising and important new area of cancer treatment and advancements in this field have the potential to cure certain cancer patients. I applaud the FDA for granting this treatment priority review, thus enabling patients in need to have access to this potentially life-saving treatment.

"I am proud of pioneers in our district like Kite Pharma for leading the way to targeted, effective cancer treatments. This marks an important milestone in the treatment of serious diseases and I’m excited to see where our science goes from here.”

###